Endurance Wealth Management, Inc. Trevena Inc Transaction History

Endurance Wealth Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 14, 2020	SELL	$0.48 - $1.75 $14,400 - $52,500	-30,000 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$1.44 - $2.24 $27,360 - $42,560	19,000 Added 172.73%	30,000 $43,000
Q1 2018 Apr 19, 2018	BUY	$1.51 - $2.06 $1,510 - $2,060	1,000 Added 10.0%	11,000 $18,000
Q4 2017 Jan 18, 2018	SELL	$1.4 - $2.6 $14,000 - $26,000	-10,000 Reduced 50.0%	10,000 $16,000
Q3 2017 Oct 19, 2017	BUY	$2.22 - $2.79 $44,400 - $55,800	20,000	20,000 $51,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Endurance Wealth Management, Inc. with notifications on news.